Meda

Meda inks deal to buy Acton Pharmaceuticals for USD 135 million

Swedish pharmaceutical firm Meda announced the signing of a deal for the USD 135 million purchase of US-based Acton Pharmaceuticals.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics